Syringe company Unilife Corp. (UNIS-NASDAQ) reports higher 4Q revenues

Posted by Laura Swartz

July 31, 2012 at 8:26 AM

Read More

Topics: Crystal Research Associates, Newsworthy Events, Unilife Corp., Prefilled Syringe

2Q Cleantech Investments of $1.6 billion Target Resource Efficiency

Posted by Laura Swartz

July 24, 2012 at 12:18 PM

Amid a depressed global economic environment, investments in cleantech were estimated to total $1.6 billion in the second quarter 2012, down from $1.9 billion in the first quarter 2012and $2.1 billion in the comparable year-ago period (second quarter 2011). Factors driving down investment include global economic uncertainties as well as political opposition to government subsidies in areas such as solar and wind power and electric vehicle development. A depressed U.S. IPO market is further hampering greentech funding efforts. 

Read More

Topics: Crystal Research Associates, nanotechnology, built environment, green infrastructure, Newsworthy Events, Soladigm

QUARTERLY UPDATE: AtheroNova (AHRO-OTC) Receives Key Patent Allowance

Posted by Laura Swartz

July 16, 2012 at 4:27 PM

Novel biotech company AtheroNova Inc. (AHRO-OTC) made a significant news announcement last week when it reported the receipt of a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its main patent. The Notice of Allowance entailed written communication from the USPTO to AtheroNova that the Company’s primary patent was allowable. A Notice of Allowance specifies the amount of issue and/or publication fees that are due within three months in order to avoid abandonment of the applications (Source: USPTO). Accordingly, AtheroNova expects to announce the official patent issuance within the next few months once the registration process is complete.  

Read More

Topics: Newsworthy Events, New Research, Crystal Research Associates, AtheroNova

Receive Our Research Notifications

About This Blog

We provide investor-based research and corporate communications services to companies worldwide. Visit our About Us page to learn more.

Posts by Topic